Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 489,500 | 2,260,800 | 1,096,000 | 2,063,900 | 1,517,900 |
| Marketable Securities | 17,100 | 13,000 | 9,300 | 7,000 | 8,500 |
| Receivables | 2,490,500 | 2,652,800 | 2,125,400 | 2,143,200 | 4,420,100 |
| Inventories | 726,800 | 1,022,200 | 757,500 | 1,285,400 | 2,786,000 |
| Income taxes - deferred | N/A | N/A | N/A | 6,608,500 | 711,600 |
| Other current assets | 4,244,000 | 3,508,400 | 4,095,600 | 3,802,100 | 38,000 |
| TOTAL | $8,755,200 | $10,091,500 | $8,579,100 | $16,658,700 | $10,486,900 |
| Non-Current Assets | |||||
| PPE Net | 1,557,200 | 1,602,400 | 1,531,300 | 1,569,900 | 2,859,000 |
| Investments And Advances | 352,600 | 405,500 | 408,700 | 498,300 | 530,300 |
| Intangibles | 110,976,600 | 113,259,800 | 114,301,400 | 113,448,500 | 124,421,300 |
| Other Non-Current Assets | 10,977,500 | 10,714,500 | 10,762,800 | 10,640,900 | 113,600 |
| TOTAL | $123,863,900 | $125,982,200 | $127,004,200 | $126,157,600 | $127,924,200 |
| Total Assets | $132,619,100 | $136,073,700 | $135,583,300 | $142,816,300 | $138,411,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,035,400 | 1,550,900 |
| Accounts payable and accrued liabilities | 4,490,100 | 4,701,100 | 4,148,600 | 4,513,500 | 5,945,000 |
| Other current liabilities | 4,284,700 | 5,425,900 | 4,089,700 | N/A | N/A |
| TOTAL | $8,867,400 | $10,195,500 | $8,292,000 | $8,133,000 | $7,649,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,075,100 | 38,551,800 | 40,133,900 | 40,648,100 | 41,319,400 |
| Deferred Revenues | N/A | N/A | N/A | 32,900 | 25,700 |
| aiOther Non-Current Liabilities | 2,257,300 | 2,313,100 | 2,597,700 | 2,534,400 | 2,073,700 |
| TOTAL | $47,110,900 | $48,429,500 | $50,702,000 | $57,203,200 | $58,687,100 |
| Total Liabilities | $55,978,300 | $58,625,000 | $58,994,000 | $65,336,200 | $66,336,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 395,952 | 395,557 | 394,687 | 394,125 | 393,636 |
| Common Shares | N/A | N/A | N/A | N/A | 4,929,700 |
| Retained earnings | 3,262,300 | 3,833,600 | 3,647,500 | 4,347,900 | -953,300 |
| Other shareholders' equity | -320,200 | 27,100 | -496,200 | -38,900 | -5,000 |
| TOTAL | $76,640,800 | $77,448,700 | $76,589,300 | $77,480,100 | $72,074,500 |
| Total Liabilities And Equity | $132,619,100 | $136,073,700 | $135,583,300 | $142,816,300 | $138,411,100 |